RAPT Therapeutics Inc (RAPT) Event May 11, 2022, 00:00 UTC (76% Positive) RAPT Therapeutics, Inc. (RAPT) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:37 a.m. 🏢 RAPT Therapeutics Inc (RAPT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-11 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-16.51M $-20.47M $3.95M +19.32% 📉 Total Assets $6.58M $6.58M N/A +0.00% ➡️ Total Liabilities $8.97M $6.58M $2.39M +36.23% 📉 Stockholders' Equity $91.64M $-231.36M $323.00M +139.61% 📈 Operating Income/Loss $-16.56M $-20.78M $4.22M +20.29% 📉 R&D Expense $13.77M $16.67M $-2.90M -17.39% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 RAPT Therapeutics Inc (RAPT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document